| Market Cap | 111.11K | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
| Income | -288.76k | Forward P/E | - | EPS next Y | - | 50D Avg Chg | 2.00% |
| Sales | 119.57k | PEG | - | EPS past 5Y | - | 200D Avg Chg | -31.00% |
| Dividend | N/A | Price/Book | N/A | EPS next 5Y | - | 52W High Chg | -91.00% |
| Recommedations | - | Quick Ratio | 0.74 | Shares Outstanding | 426.95M | 52W Low Chg | 39.00% |
| Insider Own | - | ROA | -35.62% | Shares Float | - | Beta | 1.42 |
| Inst Own | - | ROE | -164.17% | Shares Shorted/Prior | -/- | Price | 0.00265 |
| Gross Margin | 66.47% | Profit Margin | -241.51% | Avg. Volume | 2,713,774 | Target Price | - |
| Oper. Margin | -289.95% | Earnings Date | - | Volume | 370,988 | Change | 6.00% |
Emergent Health Corp. develops and sells regenerative medicine, neutraceuticals, and phytonutritionals. Its products comprise Vita-Stim, a nutrient that enhances the immune system, nourishes stem cells, and maintains health; Neuvitale, which nourishes stem cells and acts as a methyl donor to protect DNA; Hungarest, a diet aid that controls appetite in the brain and stomach; EmergentO2, water oxygenator, which increases oxygen in the blood stream; and products for reducing facial wrinkles. The company distributes its products through health food stores, pharmacies, and various other retail outlets throughout the United States and internationally. Emergent Health Corp. was incorporated in 2006 and is based in King of Prussia, Pennsylvania. As of August 26, 2014, Emergent Health Corp was taken private.
